Back to results
US 5,292,962 AGranted
Intermediates to 1-phenyl-3-naphthalenyloxy-propanamines
AssigneeEli Lilly and Company
InventorsCharles A. Alt, Roger L. Robey, Eldon E. Van Meter
Life of this patent
Estimating the term…
Abstract
Intermediates to 1-phenyl-3-naphthalenyloxypropanamines which selectively inhibit serotonin uptake and are useful for treating a variety of disorders linked to decreased neurotransmission of serotonin in mammals.
Claims20
A compound of the formula I ##STR5## wherein:
- R.sub.1 hydrogen, halo, C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.3 alkoxy or halo-C.sub.1 -C.sub.5 alkyl;
- each R.sub.2, R.sub.3 and R.sub.4 independently is hydrogen, halo C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.3 alkoxy or trifluoromethyl;
- or any adjacent two of R.sub.2, R.sub.3 and R.sub.4 can be combined to form methylenedioxy.
Dependencies are inferred from the claim text.